Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 USD | +7.47% | -0.43% | -64.04% |
04-18 | Sector Update: Health Care Stocks Ease in Afternoon Trading | MT |
04-18 | Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 10.31M 826M |
---|---|---|---|---|---|
Net income 2024 * | -30M -2.4B | Net income 2025 * | -33M -2.64B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.4
x | P/E ratio 2025 * |
-0.57
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Moleculin Biotech, Inc.
1 day | +7.47% | ||
1 week | -0.43% | ||
Current month | -21.66% | ||
1 month | -1.07% | ||
3 months | -36.49% | ||
6 months | -36.75% | ||
Current year | -64.04% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 27/07/15 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 27/07/15 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 21/08/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 27/07/15 |
Michael Cannon
BRD | Director/Board Member | 78 | 30/06/15 |
John Climaco
BRD | Director/Board Member | 55 | 23/07/17 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 4.63 | +7.47% | 24,042 |
25/04/24 | 4.308 | -0.96% | 22,596 |
24/04/24 | 4.35 | -5.43% | 7,420 |
23/04/24 | 4.6 | +6.98% | 7,430 |
22/04/24 | 4.3 | -7.53% | 16,771 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.04% | 10.31M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MBRX Stock